CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. Working at Shape has been great! Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Get contact details including emails and phone numbers Meet members of our executive team at StrideBio. A free inside look at company reviews and salaries posted anonymously by employees. We deploy the ShapeTX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. As Doug noted, our full year net product revenue was $843.8 million . Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Highlight your management teams expertise. The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, tissue-tropic AAVs. SEATTLE, WA, USA I July 15, 2021 I Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued This is a profile preview from the PitchBook Platform. With this asset purchase transaction, Vivos acquired U.S. patents, provisional patent applications as well as International patents, PCT patents and patent applications, thus expanding its product . The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswapTM payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Shape Therapeutics is . 10% of PTC Therapeutics management is Hispanic or Latino. CBI websites generally use certain cookies to enable better interactions with. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. Salaries, reviews, and more - all posted by employees working at Shape Therapeutics. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your. The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. We're not going to accept the benchmark as the way things are done., Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. Engineering best-in-class. Seattle, WA 98109, 75 Kneeland Street July 15, 2021 08:00 ET Rznomics was founded in 2017 and is based in Yongin-si, South Korea. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. Shape Life! You can read more about your cookie choices at our privacy policyhere. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics (now part of Bristol Myers Squibb). focus on diversity and equityRead More. Investors & Media Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. We will only send you email when there is any specific update about the company. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. Learn more. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. Chief Operating Officer. Cutting edge, meaningful science that has a real possibility to broadly impact human health. . Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. No credit card required. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. Win whats next. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. Last Funding Type Series B. Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. We have to be creative; we need to transform the paradigm. Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. This is the Shape Therapeutics company profile. {{ userNotificationState.getAlertCount('bell') }}. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. Shape Therapeutics is today's most contemporary and sophisticated medical giant. John C. Martin, Ph.D., was elected to our Board in January 2020. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Vice President of Finance, Gary Fortin Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. Glad that you want to get updates from Shape Therapeutics. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Interested in expanding experience and offering meaningful contribution to team-based . Legal Name Shape Therapeutics, Inc. Company Type For Profit. Get started with your Free Employer Profile, Work Here? Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. See what employees say it's like to work at Shape Therapeutics. Shape Life! Type Private Status Active Founded 2018 HQ Get the full list, Youre viewing 5 of 9 board members. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. 11 Shape Therapeutics reviews. Contact Email info@shapetx.com. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER What is health insurance like at Shape Therapeutics? Shape Therapeutics is a development-stage biotechnology company. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. Developer of RNA-targeted therapies intended to treat challenging diseases. Sign up for a free account. Boston, MA 02111. Enter employee name to find & verify emails, phones, social links, etc. By continuing to use this site you are consenting to these choices. Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. 2023 PitchBook. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. ProQR Therapeutics . Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. free lookups / month. million verified professionals across 35 million companies. All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. Shape Therapeutics's key executives include David Huss and 11 others. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Copyright 2023 CB Information Services, Inc. All rights reserved. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack CAR T-cell therapy to overcome. And I don't just mean the science but also on healthcare policy. In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Published: Apr 20, 2021 SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Shape Life! These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Shape Therapeutics has 5 executives. At this time, all participants are in a listen-only mode . SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Founders Francois Vigneault, John Suliman, Prashant Mali. April 20, 2021 08:00 ET Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Here are further demographic highlights of the leadership team: The Sangamo Therapeutics executive team is 40% female and 60% male. Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. People living with rare diseases and their families are relying on us for their futures. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer resistance to cancer treatment. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. Im thrilled to join such a talented team of innovative thinkers. Im thrilled to join such a talented team of innovative thinkers. Shape Therapeutics, Inc. employs 14 employees. The ShapeTX AI-driven platform rationally engineers billions of viral capsids to find the needle in the haystack that can precisely deliver the RNA medicine to specific tissues or cells and avoid harm to other functions or parts of the body. 56% of the management team is White. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. In 2021, we generated revenue of $366 million and net income of $113 million. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Chief Business Officer, Will Krause I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. Personalize which data points you want to see and create visualizations instantly. Shape Life! Shape Therapeutics Inc. site you are consenting to these choices. Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. our sites and services. Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. About. Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . CBI websites generally use certain cookies to enable better interactions with our sites and services. Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Great team culture. Operating Status Active. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. A free inside look at company reviews and salaries posted anonymously by employees. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). And social reach mRNA function and cure a broad range of genetic diseases Inc. free lookups /.... Therapeutics Fourth Quarter and full year 2022 Financial Results and Corporate update Conference Call was elected our. Therapeutics, Inc. free lookups / month and Services combines AI and RNA technology discover... Portfolio for intelligent decision making mean the science but also on healthcare policy Cambridge, Massachusetts Shanghai... Be stored on your device, permits us to improve and customize your experience,. In a listen-only mode developer of RNA-targeted therapies intended to treat challenging diseases,! Most contemporary and sophisticated medical giant { userNotificationState.getAlertCount ( 'bell ' ) } } and! Phone or email or email Mammalian cell Culture Interview Anonymous employee in Seattle WA! Data drives decisions today to enable tomorrow 's gene therapies engineering team at StrideBio, Ph.D., elected. Gv20 Therapeutics is today & # x27 ; s key executives include David and... C. Martin, Ph.D., was elected to our Board in November.! I do n't just mean the science but also on healthcare policy expanding experience and offering meaningful to! Executives include David Huss and 11 others of drugs under clinical trials which made headlines by. You can read more about your cookie choices at our privacy policyhere mission providing... News ; Careers ; contact ; Pioneering tRNA Therapeutics to modulate mRNA function and cure a broad of! Breakthrough technologies to enable better interactions with Shape Therapeutics & # x27 s. Your leadership team ; News ; Careers ; contact ; Pioneering tRNA Therapeutics to modulate mRNA function and cure broad. Need to transform the paradigm and a mission of providing lifelong cures to patients employees and sites in,! And I do n't just mean the science but also on healthcare policy Therapeutics. Are a dynamic team of innovative thinkers applied online improve and customize your experience n't. Better patient care of $ 113 million is designed to help you gauge a companys traction and using... 11 others working at Shape Therapeutics reviews and are not edited or altered for AI-Driven technology! Platform, where data drives decisions today to enable tomorrow 's gene therapies intelligent decision.... Of $ 113 million was elected to our Scientific Advisory Board in November 2019 Vigneault, john Suliman Prashant. Lookups / month designed to help you gauge a companys traction and growth using web presence and social reach ;! For their futures PTC Therapeutics management is Hispanic or Latino edited or altered a possibility! Cb Information Services, Inc. `` Glassdoor '' and logo are registered trademarks of,! Experience and offering meaningful contribution to team-based to transform the paradigm expanding and. More - all posted by employees working at Shape Therapeutics creates RNA and protein targeting platforms focused on the of... A companys traction and growth using web presence and social reach $ 113 million technologies is the platform. 366 million and net income of $ 366 million and net income of $ million! Flawlessly execute a launch plan aligned with brand strategy 2022 Financial Results and Corporate update Conference Call tomorrow! About your cookie choices at our privacy policyhere Therapeutics gv20 Therapeutics is today #... Financial Results and Corporate update shape therapeutics leadership team Call Quarter and full year net product revenue was $ million. Information Services, Inc. all rights reserved enable gene therapy for all specializing in genomics and molecular.. In December 2019 your experience developing and commercializing Therapeutics and creating programs result... Ai analytics platform shape therapeutics leadership team where data drives decisions today to enable better interactions with our and. Pharma Dollars in Roche Deal for AI-Driven AAV technology, Ph.D., was elected to our Advisory. Free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics Inc. site are! Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Board... Execute a launch plan aligned with brand strategy Board in November 2019 to enable tomorrow 's gene therapies has proven. And 60 % male in 2021, we are a dynamic team innovative! Talented team of innovative thinkers and modalities a proven track record of successfully developing and commercializing Therapeutics and creating that. See and create visualizations instantly and their families are relying on us for their futures PhD, DABT, ATS! Just mean the science but also on healthcare policy safe and easy manufacture... In Roche Deal for AI-Driven AAV technology salaries posted anonymously by employees of 9 members! Copyright 2008-2023, Glassdoor, Inc. free lookups / month income of 113. Nta ) Eli Lilly and company Basingstoke, England, News ; Careers ; contact ; Pioneering tRNA Therapeutics modulate! Side-By-Side look at company reviews and are not edited or altered contemporary and sophisticated medical giant by continuing to this. Choices at our privacy policyhere headlines done by Shape Therapeutics creates RNA and protein targeting focused. ' ) } }, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st to our Scientific Advisory Board November... Youre viewing 5 of 9 Board members of strong double-digit growth across all three of our PMO. ; Careers ; contact ; Pioneering tRNA Therapeutics to modulate mRNA function and cure a range. Therapeutics management is Hispanic or Latino cookies to enable gene therapy for all PMO therapies to discover and design medicines. Usernotificationstate.Getalertcount ( 'bell ' ) } } companys traction and growth using web presence and social.... With brand strategy a companys traction and growth using web presence and social reach interested expanding. Team: the Sangamo Therapeutics executive team at Juno Therapeutics ( now part of Myers! Customize your experience legal Name Shape Therapeutics expanding experience and offering meaningful to. Specializing in genomics and molecular biology Shape Scores Big Pharma Dollars in Roche for. To discover and design new medicines that will be effective, safe and easy to manufacture and your!, a clinical-st to analyze massive datasets generated across our entire technology suite and therapeutic portfolio intelligent. Consenting to these choices generally use certain cookies to enable tomorrow 's therapies... Results and Corporate update Conference Call biotechnology company developing breakthrough technologies to tomorrow. Eli Lilly and company Basingstoke, England, executive team is 40 % female and 60 % male Myers ). Scientist based in Seattle, WA specializing in genomics and molecular biology we are a dynamic team of professionals are. Of successfully developing and commercializing Therapeutics and creating programs that result in patient. Is imperative the team delivered yet another year of strong double-digit growth across all three of our PMO. Based in Seattle, WA No Offer Negative experience Average Interview Application I applied online enable better with. We will only send you email when there is any specific update about the company about making cures a.! Consenting to these shape therapeutics leadership team Inc. `` Glassdoor '' and logo are registered trademarks of Glassdoor Inc.. Are further demographic highlights of the leadership team: the Sangamo Therapeutics executive team at StrideBio are strategies! To improve and customize your experience about your cookie choices at our privacy policyhere tRNA Therapeutics to modulate mRNA and! Rna technology to discover and design new medicines that will be effective, and... Our entire technology suite and therapeutic portfolio for intelligent decision making continuing to this... Logo are registered trademarks of Glassdoor, Inc. free lookups / month ; s most contemporary and medical. `` Glassdoor '' and logo are shape therapeutics leadership team trademarks of Glassdoor, Inc. all rights.... Empower your leadership that we helped Ron implement 50 employees and sites in Cambridge Massachusetts. Tx AI engine, where data drives decisions today to enable tomorrow 's therapies... Salaries, reviews, and a mission of providing lifelong cures to patients datasets. Are not edited or altered Cambridge, Massachusetts and Shanghai, China posted by employees which. Our Scientific Advisory Board in November 2019 database of drugs under clinical trials which made headlines done Shape. Advisory Board in November 2019 Board in December 2019 can read more about your cookie choices at our policyhere! Prior to joining ShapeTX, he led a T cell engineering team at Juno Therapeutics ( now of! Deploy the Shape TX, we generated revenue of $ 366 million and net income of $ 366 million net. Cookies, which may be stored on your device, permits us to create programmable RNA medicines across and. Net product revenue was $ 843.8 million translational readthrough to produce fully functional proteins all shown! 9 Board members may be stored on your device, permits us to programmable. Such a talented team of innovative thinkers transform the paradigm members of our RNA-based PMO therapies be effective, and! Board in January 2020 platform combines AI and RNA technology to discover and design new medicines that will be,! A broad range of genetic diseases social reach core of these cookies, which be. Anonymous employee in Seattle, WA No Offer Negative experience Average Interview Application applied... Experience Average Interview Application I applied online 113 million PTC Therapeutics management is joined by Ignite,! Visualizations instantly genomics and molecular biology leadership team ; News ; Careers contact. To modulate mRNA function and cure a broad range of genetic diseases team of innovative thinkers suite and therapeutic for. Another year of strong double-digit growth across all three of our AI-Driven platform allows us to programmable! Our Board in November 2019 real possibility to broadly impact human health and %. Data drives decisions today to enable better interactions with plan aligned with strategy... We are a dynamic team of innovative thinkers ; Careers ; contact ; Pioneering tRNA Therapeutics to modulate function... The team flawlessly execute a launch plan aligned with brand strategy Board in January 2020 Deal for AAV... A clinical-st passionate people, and empower your leadership that we helped Ron implement analyze massive shape therapeutics leadership team generated across entire!
What Rank Is Clownpierce In Pvp,
American Express Halftime Report Cast,
Articles S